Aperiomics was selected from among five finalists as the Health & Life Sciences Innovator of the Year by the Northern Virginia Chamber of Commerce in their 2PndP Annual Greater Washington Innovation Awards. According to Northern Virginia Chamber President and CEO, Jim Corcoran, these award winners “represent the most forward thinking companies in our region. They are shaping the future of business as we know it.”
Aperiomics CEO Crystal Icenhour, PhD, commented, “We were honored to be named among the other finalists and are indeed proud to be selected for this award. We hope this recognition of our young company will help to boost awareness of our revolutionary technology that has the potential to transform diagnosis and treatment of infectious diseases.”
The Northern Virginia Chamber represents local employers with more than 500,000 regional employees and has been a partner of local businesses for over 90 years.
Based in Ashburn, VA, Aperiomics was founded in October 2013 as a spinoff from the Computational Biology Institute at George Washington University’s Virginia Science and Technology Campus in Sterling. The company combines genomics and informatics in an innovative way to produce faster and more accurate results than culture-based or even other molecular-based diagnostic approaches.
From a single test, Aperiomics can simultaneously test for all pathogens whether bacteria, virus, fungus or parasite. The sample can be tissue, plant, animal, or environmental. Based on its unique process that capitalizes on high-throughput Next-generation sequencing and advanced Bayesian statistics, Aperiomics can not only find a “needle in a haystack” but can also reveal that a “needle” is lurking there – even if it is a formerly unknown pathogen. This effective system translates into improved human and animal health, reduced risk to public health, and significant health care cost savings.
Recently, Aperiomics announced its second National Science Foundation Award in a year. With this Small Business Innovation Research (SBIR) Phase II grant, the company’s NSF funding through a total of three grants has now reached nearly a million dollars. In addition to support from the National Science Foundation’s SBIR and iCORP programs, Aperiomics has also received funding from the Center for Innovative Technologies of Herndon, VA, and from private investments.
For more information, please visit www.aperiomics.com or look for the company on LinkedIn, Twitter and AngelList.